Geiger Counter Limited
Plc
Monthly Investor Report -
24th February 2025
( All Factsheet data is at 31
January 2025)
The full monthly factsheet is now
available on the Company's website and a summary can be found
below.
NCIM - Geiger Counter Ltd
- Fund Page for Geiger Counter Ltd
Enquiries:
For
the Investment Manager
CQS (UK) LLP
Craig Cleland
0207 201 5368
For
the Company Secretary and Administrator
R&H Fund Services (Jersey)
Limited
Jane De Barros/Katie De La
Cour
01534 825259/01534
825337
-----------------------------------------------------------------------
Fund Description
The objective of Geiger Counter
Limited is to provide investors with the potential for capital
growth through investment primarily in the securities of companies
involved in the exploration, development and production of energy,
predominantly within the uranium industry. Up to 30% of the value
of the Company's investment portfolio may be invested in other
resource- related companies from outside the energy
sector.
Portfolio Managers
Keith Watson and Robert
Crayfourd
Key
Advantages for the Investor
· Access
to mining assets in the uranium sector
· May
benefit from embedded subscription share
· Low
correlation to major asset classes
Key
Fund Facts1
Total Gross
Assets
|
£89.2
|
Reference
Currency
|
GBP
|
Ordinary Shares:
|
|
Net Asset Value
|
53.87p
|
Mid-Market Price
|
51.30p
|
Net gearing4
|
21.68%
|
Discount
|
(4.77%)
|
Ordinary Share and NAV Performance2
|
One
Month
|
Three
Months
|
One
Year
|
Three
Years
|
Five
Years
|
|
(%)
|
(%)
|
(%)
|
(%)
|
(%)
|
NAV
|
2.96
|
(9.45)
|
(31.27)
|
30.78
|
321.52
|
Share Price
|
13.37
|
11.52
|
(17.26)
|
19.30
|
273.09
|
Commentary3
The U3O8 (Uranium) spot price
closed January 2.4% lower at $71.15/lb with two factors coinciding
to weigh on the uranium mining sector. Firstly, Kazatomprom's Q4'24
operational update showed stronger production following an
earlier-than-expected restart of its Inkai operation. This helped
to lift the group's final quarter output to 6.5ktU/16.9Mlbs U3O8
(on a 100% basis), around 1ktU/2.6Mlbs higher than estimated.
Notably however, Kazatomprom's full year 2025 production guidance
remained unchanged at 25.0-26.5ktU (on a 100%, equivalent to
65.0-68.9Mlb U3O8). Secondly, sentiment towards the sector reacted
negatively to news of China's Deepseek Artificial Intelligence (AI)
developments. This led investors to question the pace of US AI
datacentre roll out and a reassessment of the potential pick-up in
electricity demand for the seemingly faster learning, less energy
intensive and lower cost technology.
Following the news, uranium mining
equities, which had started the year well, dropped sharply and the
Company's positive gain of 17% prior to the announcement was
largely unwound with the NAV closing the month with a 3% gain. This
compared to 2.6% sterling return registered by the Solactive
Uranium Pure Play Index. In a further example of the price
volatility in the sector, utility Constellation, which provides
baseload nuclear power - and now also gas power - that recently
signed an agreement to supply Microsoft with power generated from
Three Mile Island, ended the month 34% higher.
Despite a negative shift in AI
sentiment and equity price volatility, we believe the outlook for
reactor fuel demand remains unchanged, underpinned by significant
growth from ongoing reactor builds in China. In addition, other
important nuclear markets also continue to move forwards on
restarting capacity. Since January month-end, encouraging
developments in Japan have been announced. In a draft strategic
energy plan, due for cabinet approval later in February, the Trade
and Industry Ministry indicated that it was seeking to renew the
country's focus on nuclear power, rather than de-emphasise
it.
Specifically the draft bill no
longer references a "reducing reliance" on nuclear energy, that had
appeared in the three previous plans, with the language changed to
a "maximisation" of nuclear power. Nuclear will account for about
20% of total energy output in 2040, based on the assumption that 30
reactors in the country are expected to be in full operation by
then.
Despite this recent softness in the
spot U3O8 price, it is also noteworthy that conversion and
enrichment prices remain at highs that we believe is indicative of
the robust long-term outlook for the sector. Following the decline
in U3O8 prices it is becoming more economic to feed more U3O8 into
the downstream processing, "overfeeding". Encouragingly, and
consistent with this, a market update by consultant UxC indicated
during the month that "additional U3O8 demand interest is
emerging", including from utilities at below US$70/lb.
|
Gross
Leverage6
(%)
|
Commitment
Leverage7
(%)
|
Geiger Counter Ltd
|
112
|
112
|
CQS (UK) LLP
4th Floor, One Strand, London WC2N 5HR, United
Kingdom
T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201
1200
CQS (US), LLC
152 West 57th Street, 40th Floor, New York, NY
10019, US
T: +1 212 259 2900 | F: +1 212 259
2699
Tavistock Communications
18 St. Swithin's Lane, London EC4N
8AD
T: +44 20 7920 3150 |
geigercounter@tavistock.co.uk
Sources: 1R&H Fund Services
(Jersey) Limited, as at the last business day of the month
indicated at the top of this report. 2R&H Fund
Services Limited/DataStream, as at the last business day of the
month indicated at the top of this report, total return performance
net of fees and expenses based on bid prices. These include
historic returns and past performance is not a reliable indicator
of future results. The value of investments can go down as well as
up. Please read the important legal notice at the end of this
document. 3Market data sourced from Bloomberg unless
otherwise stated. The Fund may since have exited some or all of the
positions detailed in the commentary. 4 BMO, UxC,
Company data September 2023. 5 www.eia.gov. 6CQS, as at the
last business day of the month indicated at the top of this report.
For methodology details see Article 4(3) of Directive 2011/61/EU
(AIFMD) and Articles 6, 7, 9 and 10 of Delegated Regulation
231/2013. 7CQS, as at the last business day of the month
indicated at the top of this report. For methodology details see
Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 8, 9,
10 and 11 of Delegated Regulation 231/2013.